Skip to main content

Table 2 Distributions of the variables of interest

From: Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy

variable

Preeclampsia (n = 8)

Unaffected group (n = 254)

P value

Median gestational age (weeks)

11 (10–13)

11 (10–13)

0.651

PAPP-A, MoM

0.63 (0.34–1.67)

1.00 (0.20–3.85)

0.046

NT, MoM

1.05 (0.81–1.28)

1.00 (0.45–1.99)

0.724

Median gestational age

16 (15–17)

16 (14–18)

0.784

MSAFP, MoM

1.00 (0.41–4.38)

1.10 (0.55–2,96)

0.550

hCG,MoM

1.66 (1.16–2.68)

1.00 (0.20–6.53)

0.001

uE3, MoM

0.97 (0.69–1.28)

1.00 (0.46–1.83)

0.521

Inhibin A, MoM

1.86(0.82–2.96)

1.00 (0.39–3.676)

0.007

Median gestational age

26 (24–27)

27 (25–27)

0.378

sFlt-11, (pg/ml)

2360 (932–4435)

1296 (166–5710)

0.001

PlGF1, (pg/ml)

219 (34.25–698)

491 (91.37–2243)

0.016

sFlt-1/PlGF1

11.9 (1.7–70.9)

2.6 (0.3–12)

0.001

Median gestational age

34 (34–36)

36 (34–37)

<0.001

sFlt-12, (pg/ml)

6275 (4307–12835)

2334 (71.61–50475)

<0.001

PlGF2, (pg/ml)

115.9 (16.48–284.9)

287.95 (6.60–1749)

0.001

sFlt-1/PlGF2

76.3 (15.1–352.7)

8 (0.8–156)

<0.001

Uterine artery doppler

   

Mean RI

0.55 (0.48–0.77)

0.57 (0.37–0.83)

0.972

Mean PI

0.94 (0.71–1.86)

0.97 (0.52–2.00)

0.949

Mean SD

2.25 (1.95–4.25)

2.35 (1.47–5.91)

0.913

Highest RI

0.58 (0.53–0.77)

0.62 (0.38–0.88)

0.526

Highest PI

1.03 (0.79–1.86)

1.06 (0.54–2.76)

0.808

Highest SD

2.40 (2.10–4.30)

2.58 (1.63–8.58)

0.642

Notch (%)

0.4

12.5

0.072

  1. Data are expressed as median (minimum–maximum).
  2. PAPP-A: pregnancy-associated plasma protein-A, NT: nuchal translucency thickness, MSAFP: alpha-fetoprotein, hCG: human chorionic gonadotropin, uE3: unconjugated estriol, sFlt-11: second trimester sFlt-1, PlGF1: second trimester PlGF, sFlt-1/PlGF1: second trimester sFlt-1/PlGF ratio, sFlt-12: third trimester sFlt-1, PlGF2: third trimester PlGF, sFlt-1/PlGF2: thirst trimester sFlt-1/PlGF ratio.